Revolution Medicines Inc. – Investors and Politicians Who Own It

RVMD, 3 share classes and securities

Investors who own it

15 tracked investors, $8.6B in shares, each from their latest 13F.

InvestorValueShare of portfolio
$2.5B11.7%
Julian i Felix BakerBaker Bros. Advisors, Q2 2026
$2.1B10.7%
$2B54.5%
Mark LampertBVF Partners, Q2 2026
$555.3M14.2%
$551.8M0.56%
Behzad AghazadehAvoro Capital Advisors, Q2 2026
$430.2M3.86%
Anand ParekhAlyeska Investment Group, Q2 2026
$123.5M0.32%
Joseph EdelmanPerceptive Advisors, Q2 2026
$98.8M1.48%
Stanley DruckenmillerDuquesne Family Office, Q2 2026
$74.8M1.44%
$51.2M0.03%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$16.4M0.75%
Joseph EdelmanPerceptive Advisors, Q2 2026
$2.3M0.04%
Howard MarksBondOaktree Capital Management, Q2 2026
$1.4M0.02%
$1.1M0.01%
Barry RitholtzRitholtz Wealth Management, Q2 2026
$758.7K0.01%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

No member of Congress is estimated to hold this stock.

InvestorActionShares now
Darwin Global ManagementAdded +381%10,629,822
Farallon Capital ManagementReduced −0.4%13,550,796
Julian i Felix BakerAdded +20%11,443,357
Mark LampertAdded +3.8%2,965,160
Alphabet (corporate investments)Reduced −11%2,946,619
Behzad AghazadehReduced −2.0%2,297,000
Joseph EdelmanAdded +104%527,600
Anand ParekhReduced −65%659,279
National Pension Service (Korea)New273,604
Stanley DruckenmillerAdded +27%399,587
Daniel SchneebergerReduced −35%87,509
Howard MarksBondNew1,150,000
Barry RitholtzAdded +8.8%4,051

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

No disclosed Congress trades in this stock.